1. Home
  2. GPUS vs VYNE Comparison

GPUS vs VYNE Comparison

Compare GPUS & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPUS
  • VYNE
  • Stock Information
  • Founded
  • GPUS 1969
  • VYNE 2003
  • Country
  • GPUS United States
  • VYNE United States
  • Employees
  • GPUS N/A
  • VYNE N/A
  • Industry
  • GPUS
  • VYNE Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPUS
  • VYNE Health Care
  • Exchange
  • GPUS NYSE
  • VYNE Nasdaq
  • Market Cap
  • GPUS 20.7M
  • VYNE 24.3M
  • IPO Year
  • GPUS 1996
  • VYNE 2018
  • Fundamental
  • Price
  • GPUS $0.66
  • VYNE $0.35
  • Analyst Decision
  • GPUS
  • VYNE Buy
  • Analyst Count
  • GPUS 0
  • VYNE 2
  • Target Price
  • GPUS N/A
  • VYNE $8.00
  • AVG Volume (30 Days)
  • GPUS 3.1M
  • VYNE 2.9M
  • Earning Date
  • GPUS 08-15-2025
  • VYNE 08-13-2025
  • Dividend Yield
  • GPUS N/A
  • VYNE N/A
  • EPS Growth
  • GPUS N/A
  • VYNE N/A
  • EPS
  • GPUS N/A
  • VYNE N/A
  • Revenue
  • GPUS $93,318,000.00
  • VYNE $605,000.00
  • Revenue This Year
  • GPUS N/A
  • VYNE $42.51
  • Revenue Next Year
  • GPUS N/A
  • VYNE N/A
  • P/E Ratio
  • GPUS N/A
  • VYNE N/A
  • Revenue Growth
  • GPUS N/A
  • VYNE 43.03
  • 52 Week Low
  • GPUS $0.64
  • VYNE $0.34
  • 52 Week High
  • GPUS $9.98
  • VYNE $4.30
  • Technical
  • Relative Strength Index (RSI)
  • GPUS N/A
  • VYNE 28.44
  • Support Level
  • GPUS N/A
  • VYNE $0.34
  • Resistance Level
  • GPUS N/A
  • VYNE $1.60
  • Average True Range (ATR)
  • GPUS 0.00
  • VYNE 0.14
  • MACD
  • GPUS 0.00
  • VYNE -0.12
  • Stochastic Oscillator
  • GPUS 0.00
  • VYNE 1.03

About GPUS HYPERSCALE DATA INC

Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has six reportable segments: Energy and Infrastructure; Technology and Finance; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Global Real Estate Equities, Inc.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: